Natural killer (NK) cells, a subgroup of innate lymphoid cells, act as the first line of defense
against cancer. Although some evidence shows that NK cells can develop in secondary …

Natural killer (NK) cells, which are innate lymphocytes endowed with potent cytotoxic
activity, have recently attracted attention as potential anticancer therapeutics. While NK cells …

Background Glioblastoma (GB) is incurable at present without established treatment options
for recurrent disease. In this phase I first-in-human clinical trial we investigated safety and …

Recent advances in cancer immunotherapy using monoclonal antibodies have dramatically
revolutionized the therapeutic strategy against advanced malignancies, inspiring the …

Cancer is a complex disease, and despite incredible progress over the last decade, it
remains the leading cause of death worldwide. Liver cancers, including hepatocellular …

Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …

Natural killer (NK) cells belong to the family of innate immune cells with the capacity to
recognize and kill tumor cells. Different phenotypes and functional properties of NK cells …

Cancer represents the leading global driver of death and is recognized as a critical obstacle
to increasing life expectancy. In recent years, with the development of precision medicine …

The malignancy with the greatest global mortality rate is lung cancer. Lung adenocarcinoma
(LUAD) is the most common subtype. The evidence demonstrated that voltage-gated …

Gene-engineered immune cell therapies have partially transformed cancer treatment, as
exemplified by the use of chimeric antigen receptor (CAR)-T cells in certain hematologic …